Division of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu 610041, Sichuan, China.
Division of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu 610041, Sichuan, China.
Cancer Epidemiol. 2019 Oct;62:101567. doi: 10.1016/j.canep.2019.101567. Epub 2019 Jul 18.
This study investigated appropriate baseline characteristics for screening a Chinese population at high risk of early lung cancer, assisted by low-dose computed tomography (LDCT) with computer-aided detection (CAD). Included is a discussion of the viability of using LDCT in the screening guideline and optimizing the guideline.
In 2014, 1016 individuals from Sichuan Province were enrolled who satisfied the criteria for high risk according to the 2013 National Comprehensive Cancer Network (NCCN) Guidelines for Non-Small Cell Lung Cancer. From 2014 to 2018, each subject was followed using LDCT with CAD, and pathologically confirmed lung cancers and baseline nodule characteristics (size and density) were recorded. Positive risk was considered a non-calcified solid or part-solid nodule on LDCT with diameter ≥5 mm and ground-glass nodule ≥8 mm, as newly recommended by the China National Lung Cancer Screening Guideline.
From 2014-2018, 13 cases of lung cancer were detected; 5 of these were early stage (38.5%). According to the NCCN criteria, 54 women were included and one of these (1.8%) developed lung cancer. The prevalence of lung cancer was 0.7% at baseline. For the entire population (excluding subjects with a tumor mass at baseline, n = 4), the rate of positivity was 20.4% at baseline; applying the Chinese criteria, the false positive rate was 19.5% (197/1012).
Further studies are warranted to establish appropriate eligible criteria and management strategies for Chinese populations.
本研究旨在探讨使用低剂量计算机断层扫描(LDCT)联合计算机辅助检测(CAD)筛查中国高危早期肺癌人群时合适的基线特征,并讨论将 LDCT 纳入筛查指南及优化指南的可行性。
2014 年,共纳入了 1016 名符合 2013 年美国国家综合癌症网络(NCCN)非小细胞肺癌指南高危标准的四川省个体。2014 年至 2018 年期间,对每位患者进行 LDCT 联合 CAD 随访,并记录经病理证实的肺癌及基线结节特征(大小和密度)。阳性风险定义为 LDCT 上直径≥5mm 的非钙化实性或部分实性结节或直径≥8mm 的磨玻璃结节,这是中国国家肺癌筛查指南的新推荐。
2014 年至 2018 年期间,共检出 13 例肺癌,其中 5 例为早期(38.5%)。按照 NCCN 标准,共纳入了 54 名女性,其中 1 名(1.8%)患有肺癌。基线时肺癌的患病率为 0.7%。对于整个人群(不包括基线时存在肿瘤的患者,n=4),基线时的阳性率为 20.4%;应用中国标准时,假阳性率为 19.5%(197/1012)。
需要进一步研究以确定适合中国人群的合适纳入标准和管理策略。